17α-Methyl-19-norprogesterone
17α-Methyl-19-norprogesterone is a synthetic progestogen and a derivative of progesterone. It is structurally related to 19-norprogesterone and is characterized by the presence of a methyl group at the 17α position. This compound is part of the class of progestins, which are synthetic analogs of the natural hormone progesterone.
Chemical Structure and Properties
17α-Methyl-19-norprogesterone has a chemical structure that is similar to that of progesterone, with modifications that enhance its progestogenic activity. The addition of a methyl group at the 17α position and the removal of the 19-methyl group are key structural changes that distinguish it from natural progesterone.
Pharmacology
As a progestogen, 17α-Methyl-19-norprogesterone binds to the progesterone receptor and mimics the effects of natural progesterone. It is used in various hormonal contraceptives and hormone replacement therapy formulations. The compound exhibits strong progestogenic activity and has been studied for its potential use in contraception and the treatment of menstrual disorders.
Medical Uses
17α-Methyl-19-norprogesterone is primarily used in the field of reproductive medicine. It is utilized in oral contraceptives, injectable contraceptives, and intrauterine devices (IUDs) to prevent ovulation and regulate the menstrual cycle. Additionally, it is used in hormone replacement therapy for the management of menopausal symptoms.
Side Effects
The side effects of 17α-Methyl-19-norprogesterone are similar to those of other progestins and may include nausea, headache, breast tenderness, and mood changes. Long-term use may be associated with an increased risk of thromboembolic events and breast cancer.
History
The development of 17α-Methyl-19-norprogesterone was part of the effort to create more effective and longer-lasting progestogens for use in contraception and hormone therapy. Its synthesis and characterization have contributed to the understanding of progestogen structure-activity relationships.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD